Literature DB >> 3800942

The relative molecular mass dependence of the anti-factor Xa properties of heparin.

V Ellis, M F Scully, V V Kakkar.   

Abstract

The effect of heparin fractions of various Mr, with high affinity for antithrombin III, on the kinetics of the reaction between factor Xa and antithrombin III have been studied using purified human proteins. Each of the heparin fractions, which varied between pentasaccharide and Mr 32,000, accelerated the inhibition of factor Xa although an increasing rate of inhibition was observed with increasing Mr. The chemically synthesized pentasaccharide preparation (Mr 1714) gave a maximum inhibition rate constant of 1.2 X 10(7) M-1 X min-1, compared with 6.3 X 10(4) M-1 X min-1 in the absence of heparin, and this rose progressively to 4.2 X 10(8) M-1 X min-1 with the two fractions of highest Mr (22,500 and 32,000). The 35-fold difference in inhibition rates observed with the high-affinity fractions was virtually abolished by the presence of 0.3 M-NaCl. The disparity in these rates of inhibition was shown to be due to a change in the Km for factor Xa when a two-substrate model of heparin catalysis was used. The Km for factor Xa rose from 28 nM for the fraction of Mr 32,000 to 770 nM for the pentasaccharide, whilst 0.3 M-NaCl also caused an increase in Km with the high-Mr fraction. These data suggest that the increased rates of inhibition observed with heparins of higher Mr may be due to an involvement of heparin binding to factor Xa as well as to antithrombin III.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3800942      PMCID: PMC1147139          DOI: 10.1042/bj2380329

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

1.  The separation of active and inactive forms of heparin.

Authors:  L H Lam; J E Silbert; R D Rosenberg
Journal:  Biochem Biophys Res Commun       Date:  1976-03-22       Impact factor: 3.575

2.  Anticoagulant action of heparin.

Authors:  P S Damus; M Hicks; R D Rosenberg
Journal:  Nature       Date:  1973-12-07       Impact factor: 49.962

3.  Anticoagulant activities of four unfractionated and fractionated heparins.

Authors:  D A Lane; I R Macgregor; R Michalski; V V Kakkar
Journal:  Thromb Res       Date:  1978-02       Impact factor: 3.944

4.  The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin.

Authors:  R E Jordan; G M Oosta; W T Gardner; R D Rosenberg
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

5.  Anticoagulant activities and effects on platelets of a heparin fragment with high affinity for antithrombin.

Authors:  E Holmer; U Lindahl; G Bäckström; L Thunberg; H Sandberg; G Söderström; L O Anderson
Journal:  Thromb Res       Date:  1980-06-15       Impact factor: 3.944

6.  On the molecular-weight-dependence of the anticoagulant activity of heparin.

Authors:  L Thunberg; U Lindahl; A Tengblad; T C Laurent; C M Jackson
Journal:  Biochem J       Date:  1979-07-01       Impact factor: 3.857

7.  The molecular-weight range of mucosal-heparin preparations.

Authors:  E A Johnson; B Mulloy
Journal:  Carbohydr Res       Date:  1976-10       Impact factor: 2.104

8.  The acceleration of the inhibition of platelet prothrombinase complex by heparin.

Authors:  V Ellis; M F Scully; V V Kakkar
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

9.  Effect of heparin on thrombin inactivation by antithrombin-III.

Authors:  R Machovich; P Arányi
Journal:  Biochem J       Date:  1978-09-01       Impact factor: 3.857

10.  Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin.

Authors:  U Lindahl; G Bäckström; L Thunberg; I G Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

View more
  5 in total

Review 1.  Tissue Engineering at the Blood-Contacting Surface: A Review of Challenges and Strategies in Vascular Graft Development.

Authors:  Daniel Radke; Wenkai Jia; Dhavan Sharma; Kemin Fena; Guifang Wang; Jeremy Goldman; Feng Zhao
Journal:  Adv Healthc Mater       Date:  2018-05-07       Impact factor: 9.933

2.  Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.

Authors:  M F Scully; V Ellis; N Seno; V V Kakkar
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

Review 3.  Revisiting the Pharmacology of Unfractionated Heparin.

Authors:  Abdallah Derbalah; Stephen Duffull; Fiona Newall; Katie Moynihan; Hesham Al-Sallami
Journal:  Clin Pharmacokinet       Date:  2019-08       Impact factor: 6.447

4.  Heparin enhances the catalytic activity of des-ETW-thrombin.

Authors:  C A Goodwin; J J Deadman; B F Le Bonniec; S Elgendy; V V Kakkar; M F Scully
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

5.  Effect of a heparan sulphate with high affinity for antithrombin III upon inactivation of thrombin and coagulation factor Xa.

Authors:  M F Scully; V Ellis; N Shah; V Kakkar
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.